<?xml version="1.0" encoding="UTF-8"?>
<p>In Canada, the annual cost of RSV-associated illness is over $18 million, and inpatient services associated with RSV/LRTI hospitalizations account for 62% of these annual expenditures [
 <xref ref-type="bibr" rid="B2">2</xref>]. Over the past two decades, the impact of LRTI hospitalizations on Canadian health resource utilization has increased as the incidences of admissions have risen from approximately 6,200 to 12,000 hospitalizations per year in children &lt;2 years of age [
 <xref ref-type="bibr" rid="B2">2</xref>,
 <xref ref-type="bibr" rid="B6">6</xref>,
 <xref ref-type="bibr" rid="B7">7</xref>]. In addition, there is a pronounced seasonal variation in the incidence of LRTIs. This is likely due to the RSV season which is defined by the timing of the onset and offset of increased RSV circulation in a community. In northern hemisphere countries, the RSV season usually runs from December through April and is associated with significantly increased pediatric admissions for LRTIs [
 <xref ref-type="bibr" rid="B8">8</xref>].
</p>
